Publication | Closed Access

N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive H2S donor via targeting E-selectin receptor and CD44 receptor for the efficient therapy of atherosclerosis

Chondroitin SulfateNanomedicineEngineeringBiochemistryTherapeutic NanomaterialsPharmaceutical NanotechnologyVascular BiologyNano-drug DeliveryCd44 ReceptorBiomedical EngineeringRos-sensitive H2s Donor